SULFATAB δισκία (400+80)mg/δισκίο για σκύλο
SULFATAB δισκία (400+80)mg/δισκίο για σκύλο
Authorised
- Sulfadiazine
- Trimethoprim
Product identification
Medicine name:
SULFATAB δισκία (400+80)mg/δισκίο για σκύλο
Active substance:
- Sulfadiazine
- Trimethoprim
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Sulfadiazine400.00/milligram(s)1.00Tablet
-
Trimethoprim80.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
-
Not applicableno withdrawal period
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01EW10
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Candilidis S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Alfasan International B.V.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 9724/11-02-2021/K-0247301
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
